By Kevin Fleming It seems that every other week we read about another hospital closure. In fact, the current pace is 30 – closures per year, according to an analysis conducted by Morgan Stanley as reported by Bloomberg News in August. The analysis, led by Vikram Malhotra, studied data from […]
Sleep Disorders
Four Patients with Chronic Lung Disease Contract Adenovirus
Voorhees Pediatric Facility, a pediatric special care nursing facility located in Voorhees, New Jersey, has had four patients with chronic lung disease contract a mild form of adenovirus. The adenovirus strain at Voorhees Pediatric Facility is not the same virus strain that was identified in the North New Jersey area […]
Insomnia Workbook for Teens
Sleep is food for the brain – especially for teens. It’s hard being a teen in today’s fast-paced world. And it’s even harder to reach your goals when you’re feeling tired and run-down. Between early school start times, social media, electronic devices, extracurricular activities, and late-night homework—teens are at the highest […]
Promising Data for First New Narcolepsy Drug in Ten Years, Pending Approval
Platform presentation highlights open-label, long-term safety and tolerability results, durability of effect over time in both EDS and cataplexy in patients with narcolepsy Harmony Biosciences, LLC (Harmony) recently presented new data on pitolisant at the 7th International Symposium on Narcolepsy in Beverly, MA. Pitolisant is an investigational product that has […]
New Study Investigates the Use of Home Monitoring to Screen Children with Down Syndrome for Risk of OSA Prior to Multichannel Sleep Studies
Masimo has announced the findings of a recently published study in which researchers investigated whether home pulse oximetry monitoring might be a useful initial screening method of determining which children with Down syndrome (DS) – who are at high risk of obstructive sleep apnea (OSA) – be recommended to undergo […]
FDA Approves ORKAMBI®, First Medicine to Treat the Underlying Cause of CF for Children Ages 2-5 Years with Most Common Form of the Disease
Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration (FDA) has approved ORKAMBI® (lumacaftor/ivacaftor) to include use in children ages 2 through 5 years with cystic fibrosis (CF) who have two copies of the F508del-CFTR mutation, making it the first medicine approved to treat the underlying cause of CF […]
Sommetrics Nabs Prestigious Award for Acute Airway Management
Sommetrics, a company providing products and services to treat disorders of the upper airway, today announced that it has been awarded the Frost & Sullivan 2018 Visionary Innovation Leadership Award for Acute Airway Management. The company is being recognized for its aerFree™ Airway Management System (AMS), the first and only […]
Clinical Trial for Treating OSA Using Cannabinoid-based Drug
Therapix Biosciences Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that on June 05, 2018, the first subject was enrolled for its Phase IIa, sponsor-initiated clinical trial using the Company’s cannabinoid-based technology THX-110 for Obstructive Sleep Apnea (OSA), at Assuta Medical Center, the largest […]
Philips Named Best Overall MedTech Company and Recognized for Best Sleep Monitoring Solution
Royal Philips, today announced it has been recognized as Best Overall MedTech Company by the 2018 MedTech Breakthrough Awards, which also recognized Philips SmartSleep as Best Sleep Monitoring Solution. Over the last few years, Philips has evolved into a health technology company, focused on delivering solutions that can improve people’s lives across the […]
Ebb Therapeutics Awarded Medical Design Excellence Award for Insomnia Therapy Device
The Medical Design Excellence Awards (MDEA), the premier awards program for the medtech industry, announced and recognized the 2018 winners across 9 product categories at its annual awards ceremony that took place on June 12, in conjunction with Medical Design and Manufacturing (MD&M) East. Every year, the MDEAs recognize significant achievements […]













